Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: Analysis of the National Cancer Database

Gynecologic Oncology

Volumn 139, Issue 1, 2015, Pages 77-83

  Rauh Hain, J Alejandro ^a   Diver, Elisabeth ^a   Meyer, Larissa A ^b   Clemmer, Joel ^a   Lu, Karen H ^b   Del Carmen, Marcela G ^a   Schorge, John O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Endometrial cancer; Uterine serous carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COMORBIDITY; FEMALE; FOLLOW UP; HUMAN; INCOME; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICARE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; SOCIAL STATUS; UTERINE SEROUS CARCINOMA; UTERUS CARCINOMA; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; EPIDEMIOLOGY; HEALTH CARE DELIVERY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; DELIVERY OF HEALTH CARE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES;

EID: 84943356515     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.08.016     Document Type: Article

References (43)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 2014 9 29
2. A. Jemal, A. Thomas, T. Murray, and M. Thun Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47
3. C.L. Creutzberg, W.L.J. van Putten, P.C.M. Koper, and et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Lancet 355 9213 2000 1404 1411
4. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, L.C. Lutgens, and et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
5. H.M. Keys, J.A. Roberts, V.L. Brunetto, and et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol. Oncol. 92 2004 744 751
6. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol. Oncol. 15 1983 10 17
7. C. Trope, G.B. Kristensen, and V.M. Abeler Clear-cell and papillary serous cancer: treatment options Best Pract. Res. Clin. Obstet. Gynaecol. 15 2001 433 446
8. B.M. Slomovitz, T.W. Burke, P.J. Eifel, and et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol. Oncol. 91 3 2003 463 469
9. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol. Oncol. 95 3 2004 593 596
10. A.N. Fader, R.D. Drake, D.M. O'Malley, H.E. Gibbons, W.K. Huh, L.J. Havrilesky, and et al. Platinum/taxane-based chemotherapy with or without radiotherapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Cancer 115 2009 2119 2127
11. National Comprehensive Cancer Network Uterine neoplasms (version 3.2012) http://www.nccn.org/professionals/physician-gls/pdf/uterine.pdf (Accessed July 8, 2012)
12. M.G. del Carmen, M. Birrer, and J.O. Schorge Uterine papillary serous cancer: a review of the literature Gyn. Onc 127 2012 651 661
13. M.V. Raval, K.Y. Bilimoria, A.K. Stewart, D.J. Bentrem, and C.Y. Ko Using the NCDB for cancer care improvement: an introduction to available quality assessment tools J. Surg. Oncol. 99 8 2009 488 490
14. J.R. Howe, L.H. Karnell, H.R. Menck, and C. Scott-Conner Adenocarcinoma of the small bowel, Review of the National Cancer Data Base, 1985-1995 Cancer 86 12 1999 2693 2706
15. M. Koshy, S.A. Fedewa, R. Malik, and et al. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA (N2) non-small-cell lung cancer J. Thorac. Oncol. 8 2013 915 922
16. A.M. Ganapathi, P.J. Speicher, B.R. Englum, A.W. Castleberry, J. Migaly, D.S. Hsu, and C.R. Mantyh Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit Dis. Colon Rectum 57 12 2014 1341-18
17. N.M. Rueth, H.Y. Lin, I. Bedrosian, S.F. Shaitelman, N.T. Ueno, Y. Shen, and G. Babiera Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis oftreatment and survival trends from the National Cancer Database J. Clin. Oncol. 32 19 2014 2018 2024
18. B. Rungruang, and A.B. Olawaiye Comprehensive surgical staging for endometrial cancer Rev. Obstet. Gynecol. 5 1 2012 28 34
19. S. Raigani, J.M. Hardacre, J. Kim, and J.B. Ammori Trends in the surgical treatment of gastric adenocarcinoma Ann. Surg. Oncol. 21 2 2014 569 574
20. C.N. Klabunde, A.L. Potosky, J.M. Legler, and et al. Development of a comorbidity index using physician claims data J. Clin. Epidemiol. 53 12 2000 1258 1267
21. M.E. Charlson, P. Pompei, K.L. Ales, and et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J. Chronic Dis. 40 5 1987 373 383
22. J.A. Rauh-Hain, J. Clemmer, R.M. Clark, L.S. Bradford, W.B. Growdon, A. Goodman, and et al. Management and outcomes for elderly women with vulvar cancer over time BJOG 121 6 2014 719 727
23. D.M. Boruta II, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol. Oncol. 115 1 2009 142 153
24. W.B. Growdon, J.A. Rauh-Hain, A. Cordon, L. Garrett, and et al. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review Int. J. Gynecol. Cancer 22 2012 417 424
25. T.A. Ayeni, M.M. AlHilli, J.N. Bakkum-Gamez, and et al. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach? Int. J. Gynecol. Cancer 25 1 2015 87 91
26. G. Sutton, J.H. Axelrod, B.N. Bundy, and et al. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group Gynecol. Oncol. 100 2 2006 349 354
27. I. Alagkiozidis, A. Grossman, N.Z. Tang, and et al. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study Int. J. Surg. 14 2015 61 66
28. J.A. Rauh-Hain, W.B. Growdon, J.O. Schorge, and et al. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma Gynecol. Oncol. 119 2 2010 299 304
29. Y. Todo, H. Kato, M. Kaneuchi, H. Watari, and et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 9721 2010 1165 1172
30. J.N. Bakkum-Gamez, A. Mariani, S.C. Dowdy, A.L. Weaver, and et al. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy Gynecol. Oncol. 132 3 2014 578 584
31. G. Bogani, A. Cromi, M. Serati, E. Di Naro, and et al. Chemotherapy reduces para-aortic node recurrences in endometrial cancer with positive pelvic and unknown para-aortic nodes Int. J. Gynecol. Cancer 25 2 2015 263 268
32. C.S. Dietrich III, S.C. Modesitt, P.D. DePriest, and et al. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC) Gynecol. Oncol. 99 3 2005 557 563
33. J.A. Rauh-Hain, S.C. Connor, J.T. Clemmer, O.W. Foley, R.M. Clark, and et al. Trends in treatment of uterine serous cancer in the Medicare population Int. J. Gynecol. Cancer 25 6 2015 1023 1030
34. H.D. Homesley, V. Filiaci, S.K. Gibbons, H.J. Long, D. Cella, N.M. Spirtos, and et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study Gynecol. Oncol. 22 2008 131 136
35. G.F. Fleming, V.L. Brunetto, D. Cella, K.Y. Look, G.C. Reid, A.R. Munkarah, and et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study J. Clin. Oncol. 22 2004 2159 2166
36. D. Miller, V. Filiaci, G. Fleming, and et al. Late-breaking abstract 1: randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study Gynecol. Oncol. 125 2012 771 773
37. W.K. Huh, M. Powell, C.A. Leath III, and et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy Gynecol. Oncol. 91 3 2003 470 475
38. H. Mahdi, P.G. Rose, M.A. Elshaikh, and et al. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasiveuterine papillary serous carcinoma. A multi-institutional study. Gynecol. Oncol. 136 3 2015 529 533
39. A. Jhingran, L.M. Ramondetta, D.C. Bodurka, and et al. A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988)uterine papillary serous carcinoma of the endometrium Gynecol. Oncol. 129 2 2013 304 309
40. M.E. Randall, V.L. Filiaci, H. Muss, and et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J. Clin. Oncol. 24 1 2006 36 44
41. G.L. Maxwell, C. Tian, J. Risinger, and et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study Cancer 107 9 2006 2197 2205
42. J.A. Rauh-Hain, A. Buskwofie, J. Clemmer, and et al. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population Obstet. Gynecol. 125 4 2015 843 851
43. K.E. Oliver, L.R. Enewold, K. Zhu, and et al. Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment Gynecol. Oncol. 123 1 2011 76 81